Forte Biosciences (FBRX) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
November 14, 2022 4:01 PM ESTÂ -FB-102 Continues to Advance Towards the Clinic and Holds Significant Market Potential Across a Variety of Indications-
-Leadership Strengthened with the Appointment of Scott Brun, M.D. to the Board of Directors-
-Ended third quarter 2022 with approximately $44.0 million in cash and cash equivalents-
DALLAS--(BUSINESS WIRE)-- Forte Biosciences, Inc.... More
